Dr Susanne Ramm
Honorary (Senior Fellow)
The Sir Peter MacCallum Department of Oncology
24 Scholarly works
3 Projects
HIGHLIGHTS
2025
Journal article
Correction: INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors(Cancer Discov 2024, 14,446–67.)
DOI: 10.1158/2159-8290.CD-25-15022025
Journal article
macpie: Scalable workflow for high-throughput transcriptomic profiling
DOI: 10.1016/j.csbj.2025.11.0022024
Journal article
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
DOI: 10.1038/s41416-024-02810-82024
Journal article
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma
DOI: 10.1093/nargab/lqae0962024
Research grants (other domestic)
Preclinical Validation of New Therapeutics for Low-Grade Serous Ovarian Cancer
2024
Journal article
Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer
DOI: 10.1002/path.62802024
Journal article
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
DOI: 10.1158/2159-8290.CD-23-0954
RECENT SCHOLARLY WORKS
2023
Journal article
High-Throughput Live and Fixed Cell Imaging Method to Screen Matrigel-Embedded Organoids
DOI: 10.3390/organoids20100012023
Journal article
MAC-Seq: Coupling Low-Cost, High-Throughput RNA-Seq with Image-Based Phenotypic Screening in 2D and 3D Cell Models
DOI: 10.1007/978-1-0716-3331-1_222023
Journal article
Radiation therapy attenuates lymphatic vessel repair by reducing VEGFR-3 signalling
DOI: 10.3389/fphar.2023.11523142021
Journal article
Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
DOI: 10.1038/s41598-021-84194-w
RECENT PROJECTS
Research Grant
ComBATing Lethal Prostate Cancer With Combination Bipolar Androgen Therapy
Research Grant
ComBATing Lethal Prostate Cancer With Combination Bipolar Androgen Therapy